The story of Viagra presents a challenging picture for shareholders. While the initial launch generated massive profits, the lapse of its patent opened the avenue to generic versions, dramatically reducing revenue. https://bookmarkfly.com/story21636753/the-copyright-and-big-pharma-a-volatile-investment